Author | Lightnews

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 12h

Hear from Assistant Research Director Frank McStay next week at the PCC's 2025 Evidence Report release! On 11/12, Frank and his fellow speakers will examine the state of rural primary care as residents of rural communities face new barriers to health coverage: thepcc.pub/Closing-The-Distance

Closing the Distance in Rural Primary Care: Evidence, Stories, and Solutions. November 12, 2025, 1:30 pm ET. Frank McStay, MPA, Assistant Research Director of Health Care Transformation, Duke-Margolis Institute for Health Policy.

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 16h

In this new Health Affairs Forefront article, Duke-Margolis researchers explore opportunities to advance rapid learning for accountable care. In particular, they highlight the potential of collaborative action through efforts like the new West Health Accelerator at Duke-Margolis: duke.is/r/w5uz

Rapid Learning For Accountable Care Adoption | Health Affairs Forefront

With accountable care more widespread than ever, the potential benefits of rapid learning collaboratives for accountable care have never been greater, both to improve outcomes and performance and to increase the confidence of organizations to participate.

www.healthaffairs.org

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 1d

Duke-Margolis has published an event report for "On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations" that summarizes the discussion that took place, offers key takeaways, and outlines next steps. You can read it here: duke.is/z/mkv3

On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations. Duke-Margolis Institute for Health Policy. September 3, 2025, 9:30 am - 4 pm ET. A hybrid public workshop. National Press Club, Washington, DC, or virtual via Zoom.

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 8d

Don't miss your chance to join this conversation! Tomorrow, we are gathering health policy experts and leaders across the public and private sectors to discuss the vision for accountable care reform, and chart a path toward delivering better health and better care for all: duke.is/p/3vx6

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 9d

Drug shortages have severely impacted patient care in the U.S. for decades. In our latest white paper, Duke-Margolis researchers propose next steps that Congress can take to address the root causes of the drug shortage problem + create a more reliable & resilient supply chain: duke.is/6/mduj

Addressing the Root Causes of Drug Shortages: Next Steps for Congress

healthpolicy.duke.edu

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 12d

Institute Director Mark McClellan and Policy Analyst Sara Debab have co-authored a new Viewpoint article in JAMA Health Forum to outline steps that reduce clinician burnout by modernizing Medicare’s risk adjustment mechanism. Read their recommendations here: duke.is/w/tdna

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 13d

A new event has been announced! Don't miss this webinar coming up on November 18, where speakers will explore opportunities to advance home-based primary care. Learn more and register here: duke.is/9/ct26

Are We There Yet? Building a Roadmap for Home-Based Primary Care. November 18, 2025, 12-1pm ET. Duke-Margolis Institute for Health Policy. Virtual via Zoom.

Reposted by Duke-Margolis Institute for Health Policy

Brystana Kaufman, PhD @brystana.bsky.social · 15d

@michellescotton.bsky.social @dukemargolis.bsky.social sharing our engagement project learnings with researchers and patient advocates at #PCORI25

1 2

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 14d

Learn more about the current state and future of the Sentinel Initiative in our upcoming workshop, convened with the FDA. A draft agenda is now available and contains more details about the topics of discussion—you can read it and register to attend here: duke.is/z/wdhk

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 15d

A draft agenda is now available for our upcoming workshop, "Individualized Therapies on the RISE"! Co-convened with the FDA, this event will explore the regulatory considerations surrounding individualized therapies that can help treat rare diseases. Read the agenda + register here: duke.is/m/jxxj

Individualized Therapies on the RISE. November 20, 2025, 9:30 am - 5:00 pm ET. Duke-Margolis Institute for Health Policy. Hybrid Location: National Press Club, Washington, DC, or virtual via Zoom.

2

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 19d

Our next event is just around the corner! We invite you to join us in DC for a timely conversation on accountable care reform. With new technological advances, policy shifts, and the lessons learned from the last decade, the next chapter of accountable care starts now: duke.is/p/3vx6

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 21d

A new hybrid workshop has been announced! Join us at the Duke in DC office on December 16 as speakers discuss ways to expand epinephrine accessibility and use, including in community settings, to reduce anaphylaxis-related morbidity and mortality. Learn more and register here: duke.is/y/x7xs

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 22d

Don't miss our Open House this Friday! Join us in our Durham office to learn more about how the Institute's research and educational initiatives help engage students across campus in health policy. We're hosting this event as part of Duke's Family Weekend: duke.is/n/x6w2

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 23d

In just a few weeks, we are hosting the Seventeenth Annual Sentinel Initiative Public Workshop with the FDA. Join us at the FDA's White Oak Campus in Maryland to learn more about the initiative's work so far as well as future directions. Register today: duke.is/z/wdhk

1 1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 27d

Join us in DC for a new workshop, "Individualized Therapies on the RISE," coming up on November 20. During this event, speakers will examine the emerging science and regulatory environment for individualized medicine programs. Learn more and register here: duke.is/m/jxxj

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 29d

Join us next Friday, 10/ 17, for our Open House! This event is an opportunity to meet the educators and mentors who are working with Duke students, and to learn more about how the Institute's research and educational initiatives help engage students across campus in health policy: duke.is/n/x6w2

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Oct 3

Don't miss this upcoming event! On November 6, we are hosting the Seventeenth Annual Sentinel Initiative Public Workshop with the FDA. Each year, this event showcases the work of the Sentinel Initiative to-date, along with future-looking discussions: duke.is/z/wdhk

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Sep 30

Accountable care—centered on personalized, coordinated, and whole-person care—is no longer the vision for the future of the American Health system: it is here, now. Join us next month for an event that will launch the new West Health Accelerator at Duke-Margolis: duke.is/p/3vx6

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Sep 23

Don't miss the upcoming Duke Climate Collaboration Symposium! On 10/1, speakers will explore opportunities to reduce health care greenhouse gas emissions and implement reforms to mitigate the health impacts of climate change: duke.is/y/s33v

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Sep 18

CMS Administrator Mehmet Oz and Duke-Margolis Director Mark McClellan will discuss CMS' vision and strategies during an upcoming event hosted by The Aspen Institute. Join in-person or virtually next Wednesday, September 24, to learn more! You can register to attend here: duke.is/b/49j5

Public Health Grand Rounds: Dr. Mehmet Oz at the Aspen Institute

support.aspeninstitute.org

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Sep 16

Join us tomorrow for our next hybrid workshop! Speakers will explore novel efficacy endpoints used in interventional clinical trials for drugs and biological products intended for patients with severe vision loss. A discussion guide is now available—you can read it and register here: duke.is/6/jzzn

The graphic features a photo of an ophthalmologist using a retinal imaging machine to examine a patient’s eyes. The accompanying text reads, “Assessing Novel Efficacy Endpoints in Ophthalmologic Rare Disease Drug and Biologics Development.” September 17, 2025, 9:30 am – 2:30 pm ET. A Hybrid Public Meeting. National Press Club, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.”

1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Sep 9

In our newest white paper, Duke-Margolis researchers share policy recommendations to strengthen drug supply chain security and resilience, including through the establishment of an international biopharmaceutical coalition. Read more here: duke.is/j/pevx

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Sep 8

On 10/7, the Duke Center of Global Mental Health is hosting their 2025 conference, "Now More than Ever: Addressing the Global Imperative of Mental Health Equity." Registration is free and all are welcome to attend: sites.duke.edu/dukegmhconf2025/

2025 Duke Global Mental Health Conference – Now More than Ever: Addressing the Global Imperative for Mental Health Equity

sites.duke.edu

1

Reposted by Duke-Margolis Institute for Health Policy

Beth Boyer @bethboyer-mph.bsky.social · Sep 5

📣JUST PUBLISHED: Our white paper on regulatory opportunities to advance generic drug repurposing is now available online! This paper explores the role of the regulator and policy actions it can take to support repurposing initiatives. @dukemargolis.bsky.social
healthpolicy.duke.edu/publications...

Regulatory Opportunities to Advance Generic Drug Repurposing

healthpolicy.duke.edu

2 1

Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · Sep 2

Duke-Margolis researchers have co-authored a paper in the Journal of Pharmacy & Pharmaceutical Sciences on pharmacogenomics (PGx) testing data. They noted that improving racial and genetic ancestry data, and increasing interoperability with EHRs, could make PGx data more actionable: duke.is/5/ygcs

Frontiers Publishing Partnerships | A systematic review of real-world evidence on the clinical relevance, characterization, and utility of CYP2D6 biomarker testing

Pharmacogenomic (PGx) research investigates how an individual’s genetic make-up impacts their drug metabolism. PGx testing can therefore inform therapeutic d...

www.frontierspartnerships.org